Mammography Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

The Global market for mammography devices is anticipated to expand from USD 3.13 billion in 2025 to USD 4.47 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.12%. These critical medical imaging instruments, which include digital mammography and breast tomosynthesis, use low-dose X-rays to generate highly detailed images of breast tissue for the preliminary detection and diagnosis of breast cancer. Market growth is mainly fueled by the climbing worldwide rate of breast cancer cases, along with heightened awareness regarding early diagnosis and routine screening programs. Additionally, an aging global female demographic and favorable government programs advocating for breast health play a major role in driving ongoing market growth.

A significant obstacle to market expansion is the worldwide scarcity of properly trained radiologists and essential medical personnel required to operate these devices and accurately analyze the results. Nevertheless, the rising frequency of breast cancer emphasizes the indispensable nature of these systems. The American Cancer Society projects that around 321,910 women in the United States will receive an invasive breast cancer diagnosis in 2026, underscoring the urgent necessity for early diagnostic technologies.

Market Driver

The escalating worldwide rate of breast cancer serves as a major driving force behind the growth of the mammography devices market. This growing frequency requires the broad implementation of early detection strategies to enhance survival rates and overall patient outcomes. A March 2026 analysis by the Global Burden of Disease Study Breast Cancer Collaborators, featured in The Lancet Oncology, estimated that 2.3 million new cases of breast cancer were diagnosed in women globally in 2023, highlighting a strong and continuous need for reliable diagnostic equipment. This widespread health issue motivates healthcare facilities around the world to upgrade their screening capacities, stimulating the acquisition of cutting-edge mammography systems.

Another key driver is the constant technological progression in imaging equipment, which continually transforms the effectiveness and functionality of mammography. Breakthroughs like 3D tomosynthesis and AI-driven diagnostics provide greater image resolution, lower recall frequencies, and better identification of minor lesions, prompting facilities to upgrade or install new systems. Emphasizing this dedication to progress, Siemens Healthineers is channeling roughly €2 billion into research and development between 2024 and 2025 to ensure ongoing product enhancements within its imaging lineup. Such technological strides are vital for drawing investments and deepening market reach. Additionally, showcasing a joint governmental and industry resolve to advance breast cancer treatment, the government of Alberta partnered with Siemens Healthineers and the Alberta Cancer Foundation in March 2025 to declare an $800 million CAD investment over eight years aimed at elevating cancer care and facilitating early detection.

Market Challenge

A major hurdle hindering the growth of the global mammography devices market is the lack of sufficiently trained radiologists and key medical staff needed to correctly operate the equipment and interpret the findings. This deficit immediately limits the ability of medical centers to perform diagnostic evaluations and breast cancer screenings, even as the desire for early detection grows. With a shortage of competent professionals, the optimal use of sophisticated mammography machinery, such as modern digital and tomosynthesis platforms, is significantly undermined.

Consequently, healthcare facilities might postpone or decrease the number of screening sessions, which causes current devices to be underused and creates hesitation toward investing in novel technologies, ultimately slowing market progress. A 2026 survey conducted by the Society of Breast Imaging revealed that 79% of practices experienced staffing shortages in breast imaging. This widespread personnel problem reduces the operational capacity of mammography clinics and forms major barriers for patients attempting to access crucial screening services, directly obstructing the market's upward trajectory.

Market Trends

A prominent trend transforming the global mammography devices market is the increasing incorporation of artificial intelligence into diagnostic routines, which boosts both operational productivity and clinical certainty. AI algorithms are being adopted more frequently to handle repetitive duties, prioritize high-risk patients, and offer decision-making assistance, optimizing the comprehensive screening procedure. This assimilation assists in mitigating the lack of radiologists and managing the surge in screening numbers. For instance, findings from the GEMINI study, featured in Nature Cancer in March 2026, showed that blending AI into screening operations reduced workloads by as much as 31% in the United Kingdom. Such productivity enhancements allow medical professionals to handle a larger caseload with current resources, speeding up patient processing and enhancing access to prompt diagnoses.

Another crucial trend involves the steady evolution of specialized imaging techniques, specifically Molecular Breast Imaging and Contrast-Enhanced Mammography. These systems supply vital secondary screening alternatives, notably for patients possessing dense breast tissue that might limit the effectiveness of standard mammography. Contrast-Enhanced Mammography delivers functional insights by illuminating blood flow within questionable lesions, while Molecular Breast Imaging employs a radioactive tracer to identify metabolically active cancer cells. Based on a 2025 review of the Density MATTERS Trial shared at ARRS 2026, Molecular Breast Imaging identified an extra 6.7 cancers per 1,000 evaluations a year following digital breast tomosynthesis. These technological enhancements broaden the diagnostic repertoire, paving the way for highly customized and successful breast cancer screening approaches.

Key Market Players

• Hologic Inc.
• Fujifilm Holdings Corporation
• Philips Healthcare
• Siemens Healthineers AG
• GE Healthcare
• Carestream Health Inc.
• Konica Minolta Inc.
• Delphinus Medical Technologies Inc.
• Analogic Corporation
• KUB Technologies Inc.

Report Scope

In this report, the Global Mammography Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Mammography Devices Market, By Product Type:

• Full-field Digital Mammography
• Film-screen Mammogram
• Breast Tomosynthesis

Mammography Devices Market, By Technology:

• Digital
• Analog

Mammography Devices Market, By End User:

• Hospitals & Clinics
• Diagnostic Centres
• Others

Mammography Devices Market, By Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Mammography Devices Market .

Available Customizations

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.